Sionna Therapeutics is trading at $3.46, up +5.49% in pre-market; no company-specific announcement explaining the November 9 pre-market move was identified. - Sionna Therapeutics is scheduled to participate in a Guggenheim investor conference at 10:30 a.m. ET; this previously announced appearance is not a confirmed catalyst. - Major U.S. indices were higher in the provided market context, which may support broader risk-on sentiment but does not establish the cause of the stockβs move.